Letter to the editor: When Guidelines Meet Reality: Implementing the 2025 ATA Recommendations for Differentiated Thyroid Cancer in Limited-Resource Settings
Authors:
- 15 July 2026
- journal article
- Published by SAGE Publications in Thyroid®
- Vol. 36 (10) , 1148-1150
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid CancerThyroid®, 2025
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid CancerThyroid®, 2025
- A decade of active surveillance for low-risk papillary thyroid carcinoma in Argentina: persistent challenges in acceptance and discontinuation ratesEndocrine, 2025
- Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin AmericaArchives of Endocrinology and Metabolism, 2024
- Ten years’ real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancerEndocrine, 2024
- The “broken chair” in patients with differentiated thyroid cancerEndocrine, 2017